RankAlpha logo
Back to Rankings

XLO

Xilio TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
XLO vs peer average
60/100
XLO vs. peer average (D vs. F)
Grade spread
B 1 · F 7
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MGX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $50.07M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMGXMetagenomi Therapeutics
XLO
Xilio Therapeutics
MGX
Metagenomi Therapeutics
Grade
D
F
Momentum
29
21
Value
57
57
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MGX

XLO / MGX
Grade Position
In line
XLO vs. peer average (D vs. F)
60/100
Momentum
29
XLO
Value
57
XLO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XLO
1
MGX
Metagenomi Therapeutics Inc Common
F
20/100
+1
2
SCYX
SCYNEXIS Inc Common
F
20/100
+1
3
ATYR
aTyr Pharma Inc Common
F
20/100
+1
4
GOSS
Gossamer Bio Inc Common
B
80/100
-2
5
RKTO
Rocket One Inc Common
F
20/100
+1
MGX is the first peer returned for this comparison set.